Head-to-head dispatch
Midi Health vs RxSpan MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Midi Health is a nationwide 50-state menopause and perimenopause telehealth platform whose weight-management lane prices a compounded GLP-1 and GLP-1/GIP menu dose by dose, by injection or sublingually, without ever naming the molecule.
Marked down on: Never names the molecule: the entire compounded menu is sold as "GLP-1" and "Dual-Action GLP-1/GIP", so you cannot tell what you are being prescribed before the visit
Desk Score
A physician-founded desk with one of the widest menus in the ranking — compounded and brand-name GLP-1 across injectable and oral routes, microdosing, plus longevity, hair, and sexual-health lines — with transparent, all-inclusive pricing across all 50 states.
From $194/mo sema · $329/mo tirz
Marked down on: Compounded semaglutide and tirzepatide are not FDA-approved — not the same as Wegovy/Ozempic or Zepbound
RxSpan MD takes this head-to-head with the higher Desk Score, 86/100 (B) against 72/100 (C) for Midi Health. Midi Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Midi Health
72/100
C
RxSpan MD
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Midi Health | RxSpan MD |
|---|---|---|
| Semaglutide | Not listed on Midi Health's site (checked August 29, 2026) | From $194/mo |
| Tirzepatide | Not listed on Midi Health's site (checked August 29, 2026) | $329/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Readers in perimenopause or menopause who want weight care from a women's-health clinician, with visits billed to commercial insurance and compounded medication from $164 per 4-week supply. | Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach. |
| Desk Score | 72/100C | 86/100B |
The verdict
Desk pick — RxSpan MDRxSpan MD takes this head-to-head with the higher Desk Score, 86/100 (B) against 72/100 (C) for Midi Health. Midi Health still holds its ground where its strengths line up with yours.
Choose Midi Health if…
Readers in perimenopause or menopause who want weight care from a women's-health clinician, with visits billed to commercial insurance and compounded medication from $164 per 4-week supply.
All 50 states
Choose RxSpan MD if…
Patients who want a broad, physician-led menu across GLP-1 routes and adjacent longevity care, with transparent all-inclusive pricing and nationwide reach.
From $194/mo sema · $329/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Midi Health · RxSpan MD.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Midi Health
- CoreAge Rx vs RxSpan MD
- Midi Health vs Vaylen
- RxSpan MD vs Vaylen
- Midi Health vs Sesame Care
- RxSpan MD vs Semaglutide Online
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.